Progenics Pharma (PGNX)

4.34 -0.22 (4.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FEDERATED INVESTORS INC /PA/ December 7, 2018 2:32 PM - SEC Filing Credit Suisse Starts Progenics Pharmaceuticals (PGNX) at Outperform December 7, 2018 5:45 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Dec 03 December 3, 2018 4:52 PM - SEC Filing Progenics Doses First Patient in Pivotal Phase 3 Study of PyL, PSMA PET Imaging Agent, for the Detection of Prostate Cancer December 3, 2018 8:30 AM - Globe NewsWire Progenics Doses First Patient in Pivotal Phase 3 Study of PyL, PSMA PET Imaging Agent, for the Detection of Prostate Cancer December 3, 2018 8:30 AM - StreetInsider Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRA® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting November 19, 2018 4:30 PM - Globe NewsWire Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRA® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting November 19, 2018 4:30 PM - StreetInsider Baker Bros. Advisors 13F for Quarter Ended Sept. 30, 2018 November 14, 2018 4:55 PM - StreetInsider Form 10-Q PROGENICS PHARMACEUTICAL For: Sep 30 November 8, 2018 4:04 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Nov 08 November 8, 2018 8:06 AM - SEC Filing Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update November 8, 2018 7:30 AM - Globe NewsWire Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update November 8, 2018 7:30 AM - StreetInsider Progenics Pharmaceuticals to Present at Upcoming Investor Conferences November 6, 2018 8:00 AM - Globe NewsWire Progenics Pharmaceuticals to Present at Upcoming Investor Conferences November 6, 2018 8:00 AM - StreetInsider Progenics Pharmaceuticals Sets Third Quarter 2018 Financial Results and Business Update Call for November 8 November 1, 2018 8:00 AM - Globe NewsWire Progenics Pharmaceuticals Sets Third Quarter 2018 Financial Results and Business Update Call for November 8 November 1, 2018 8:00 AM - StreetInsider Form EFFECT PROGENICS PHARMACEUTICAL October 25, 2018 6:07 AM - SEC Filing Recent Analysis Shows Progenics Pharmaceuticals, Catabasis Pharmaceuticals, Warrior Met Coal, Preformed Line Products, Express, and Sanmina Market Influences — Renewed Outlook, Key Drivers of Growth October 18, 2018 8:25 AM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Oct 12 October 12, 2018 4:47 PM - SEC Filing Form S-3 PROGENICS PHARMACEUTICAL October 12, 2018 4:18 PM - SEC Filing Pre-Open Movers 10/12: (CORI) (TTPH) (SQ) Higher; (IMDZ) (TRVN) Lower (more...) October 12, 2018 9:20 AM - StreetInsider After-Hours Stock Movers 10/11: (CORI) (TTPH) (PGNX) Higher; (TRVN) (IMDZ) Lower (more...) October 11, 2018 5:42 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Oct 11 October 11, 2018 5:10 PM - SEC Filing Progenics Pharma (PGNX) Advances 1095 into Phase 2 Clinical Development Following Discussions with the FDA October 11, 2018 4:03 PM - StreetInsider Progenics Advances 1095, PSMA-Targeted Therapeutic Candidate for the Treatment of Metastatic Prostate Cancer, into Phase 2 Clinical Development Following Discussions with the FDA October 11, 2018 4:01 PM - Globe NewsWire Progenics Advances 1095, PSMA-Targeted Therapeutic Candidate for the Treatment of Metastatic Prostate Cancer, into Phase 2 Clinical Development Following Discussions with the FDA October 11, 2018 4:01 PM - StreetInsider Progenics Pharma (PGNX) Announces Publication of Pivotal Trial of AZEDRA in JNM October 9, 2018 8:32 AM - StreetInsider Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine October 9, 2018 8:30 AM - Globe NewsWire Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine October 9, 2018 8:30 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Oct 05 October 5, 2018 7:41 AM - SEC Filing Progenics Pharma (PGNX) to Resume Trading at 8 am ET October 5, 2018 7:39 AM - StreetInsider Progenics Pharma (PGNX) Highlights Data from Phase 2/3 Trial of PSMA PET Imaging Agent PyL for Detection of Prostate Cancer October 5, 2018 7:31 AM - StreetInsider Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer October 5, 2018 7:30 AM - Globe NewsWire Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer October 5, 2018 7:30 AM - StreetInsider Progenics Pharma (PGNX) Halted, News Pending October 5, 2018 7:25 AM - StreetInsider Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference September 25, 2018 8:30 AM - Globe NewsWire Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference September 25, 2018 8:30 AM - StreetInsider Form SC 13G PROGENICS PHARMACEUTICAL Filed by: ARMISTICE CAPITAL, LLC September 24, 2018 5:22 PM - SEC Filing Progenics Pharma (PGNX) Reports Addition of AZEDRA (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:02 AM - StreetInsider Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:00 AM - Globe NewsWire Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma September 17, 2018 6:00 AM - StreetInsider Progenics Pharmaceuticals (PGNX) Sell-Off 'Seems Overdone' - BTIG September 13, 2018 11:53 AM - StreetInsider Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Buy September 13, 2018 11:30 AM - StreetInsider Pre-Open Movers 09/13: (PI) (XBIT) (GNC) Higher; (PVTL) (PGNX) (FRED) Lower (more...) September 13, 2018 9:17 AM - StreetInsider After-Hours Stock Movers 09/12: (PI) (TLRD) Higher; (PVTL) (PGNX) (SRTS) Lower (more...) September 12, 2018 6:15 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Sep 12 September 12, 2018 4:16 PM - SEC Filing Progenics Pharma (PGNX) Phase 3 Study for Prostate Cancer Imaging Agent 1404 Doesn't Meet Primary Endpoint September 12, 2018 4:01 PM - StreetInsider Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 September 12, 2018 4:01 PM - Globe NewsWire Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404 September 12, 2018 4:01 PM - StreetInsider Progenics Pharma (PGNX) Halted, News Pending September 12, 2018 4:00 PM - StreetInsider Full Article List